These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

386 related items for PubMed ID: 17023492

  • 21. [Can anemia be corrected in hemodialysis patients with thalassaemia minor? ].
    Di Iorio B, Guastaferro P, Gironda A, Marano V, Morrongiello L, Cillo N, Zito B, Nigro F, Frieri A, Rubino R, Bellizzi V.
    G Ital Nefrol; 2002; 19(5):552-9. PubMed ID: 12439845
    [Abstract] [Full Text] [Related]

  • 22. Staff-assisted nursing home haemodialysis: patient characteristics and outcomes.
    Reddy NC, Korbet SM, Wozniak JA, Floramo SL, Lewis EJ.
    Nephrol Dial Transplant; 2007 May; 22(5):1399-406. PubMed ID: 17259652
    [Abstract] [Full Text] [Related]

  • 23. [Risk factors associated with survival in patients in a peritoneal dialysis program].
    Sancho A, Pérez Ruixo JJ, Górriz JL, Miguel A, García Ramón R, Avila A.
    Nefrologia; 2001 May; 21(2):160-6. PubMed ID: 11464649
    [Abstract] [Full Text] [Related]

  • 24. Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia.
    Palazzuoli A, Silverberg D, Iovine F, Capobianco S, Giannotti G, Calabrò A, Campagna SM, Nuti R.
    Am Heart J; 2006 Dec; 152(6):1096.e9-15. PubMed ID: 17161060
    [Abstract] [Full Text] [Related]

  • 25. Serum ferritin is a marker of morbidity and mortality in hemodialysis patients.
    Kalantar-Zadeh K, Don BR, Rodriguez RA, Humphreys MH.
    Am J Kidney Dis; 2001 Mar; 37(3):564-72. PubMed ID: 11228181
    [Abstract] [Full Text] [Related]

  • 26. Changes in hemoglobin level distribution in US dialysis patients from June 2006 to November 2008.
    Spiegel DM, Khan I, Krishnan M, Mayne TJ.
    Am J Kidney Dis; 2010 Jan; 55(1):113-20. PubMed ID: 19932539
    [Abstract] [Full Text] [Related]

  • 27. Treatment of anemia in renal transplantation: impact of a stricter application of hemoglobin targets.
    Gentil MA, Pérez-Valdivia MA, González-Roncero FM, López-Mendoza M, Cabello V, Bernal G, Suñer M, Pereira P.
    Transplant Proc; 2008 Nov; 40(9):2916-8. PubMed ID: 19010146
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Morbidity and mortality in patients on dialysis: the impact of hemoglobin levels.
    Brattich M.
    Nephrol Nurs J; 2006 Nov; 33(1):64-7, 90; quiz 68-9. PubMed ID: 16538929
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Biocompatibility and permeability of dialyzer membranes do not affect anemia, erythropoietin dosage or mortality in japanese patients on chronic non-reuse hemodialysis: a prospective cohort study from the J-DOPPS II study.
    Yokoyama H, Kawaguchi T, Wada T, Takahashi Y, Higashi T, Yamazaki S, Fukuhara S, Akiba T, Akizawa T, Asano Y, Kurokawa K, Saito A, J-DOPPS Research Group.
    Nephron Clin Pract; 2008 Nov; 109(2):c100-8. PubMed ID: 18596379
    [Abstract] [Full Text] [Related]

  • 39. Self-reported appetite, hospitalization and death in haemodialysis patients: findings from the Hemodialysis (HEMO) Study.
    Burrowes JD, Larive B, Chertow GM, Cockram DB, Dwyer JT, Greene T, Kusek JW, Leung J, Rocco MV, Hemodialysis (HEMO) Study Group.
    Nephrol Dial Transplant; 2005 Dec; 20(12):2765-74. PubMed ID: 16204298
    [Abstract] [Full Text] [Related]

  • 40. The continuous erythropoietin receptor activator (C.E.R.A.) corrects anemia at extended administration intervals in patients with chronic kidney disease not on dialysis: results of a phase II study.
    Provenzano R, Besarab A, Macdougall IC, Ellison DH, Maxwell AP, Sulowicz W, Klinger M, Rutkowski B, Correa-Rotter R, Dougherty FC, BA 16528 Study Investigators.
    Clin Nephrol; 2007 May; 67(5):306-17. PubMed ID: 17542340
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.